Sergio Padilla

Sergio Padilla

Auto-generated profile, based on publicly available information

Sergio Padilla

Infectious Diseases Unit, Hospital General Universitario de Elche, Universidad Miguel Hernández, Elche, Spain

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Current HIV Research
Verified
Journal Article
Closed access
PDF file
FGFélix Gutiérrez
Félix Gutiérrez
SPSergio Padilla
Sergio Padilla
MMMar Masia
Mar Masia
José A. OteoJosé A. Oteo
José A. Oteo
Santiago Moreno GuillénSantiago Moreno Guillén
Santiago Moreno Guillén
JHJose Hernandez-Quero
Jose Hernandez-Quero
To describe characteristics and prognosis of patients with suboptimal immunological response to combined antiretroviral therapy (CART). Using data from a multicenter cohort study, we selected patients who initiated CART and showed suboptimal CD4-T cell response (defined as < 50 cells/L increase) after 1 year of therapy, despite sustained virological suppression. Characteristics of those patients were compared with subjects who showed optimal immunological response. Of 650 patients with virological suppression, 108 (16.6%) showed suboptimal CD4-T cell response. Independent predictors of suboptimal response were previous injection drug use (OR, 1.85; 95% CI, 1.12-2.98) and age at CART initiation (OR, 1.04 per year increase; 95%CI, 1.01-1.06). Hepatitis C virus coinfection was not associated with impaired inmunological response. As compared with patients with optimal immunological response, those with suboptimal response had a higher mortality rate (3.22 versus 0.71 per 100 person-years; p=.001), but a similar rate of new AIDSdefining events. In patients with sustained virological suppression with CART, previous injection drug use, but not hepatitis C virus coinfection, and older age at initiation of therapy were associated with suboptimal CD4 T-cell responses. Patients with suboptimal response had a higher mortality over time, mainly due to diseases other than AIDS-defining events.

30 November 2007 in Atherosclerosis
Verified
Journal Article
Closed access
PDF file
MMMar Masiá
Mar Masiá
EBEnrique Bernal-Morell
Enrique Bernal-Morell
SPSergio Padilla
Sergio Padilla
MGMaría Luisa Graells
María Luisa Graells
IJInmaculada Jarrín
Inmaculada Jarrín
FGFélix Gutiérrez
Félix Gutiérrez

15 December 2004 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
SPSergio Padilla
Sergio Padilla
JGJuan A. Gallego
Juan A. Gallego
MMMar Masiá
Mar Masiá
FGFélix Gutiérrez
Félix Gutiérrez
We assessed the value of computed tomography (CT) and anthropometric skinfold analysis for evaluating subcutaneous facial fat in human immunodeficiency virus-infected patients. Patients with facial lipoatrophy had smaller areas of facial adipose tissue, lower ratios of adipose tissue area to total tissue area of the face, and lower malar skinfold values, compared with patients without facial wasting. CT may be a useful technique to diagnose and monitor facial lipoatrophy.

30 June 2009 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
Jose-Manuel Ramos-RinconJose-Manuel Ramos-Rincon
Jose-Manuel Ramos-Rincon
MMMar Masiá
Mar Masiá
SPSergio Padilla
Sergio Padilla
EGEduardo Garcia-Pachon
Eduardo Garcia-Pachon
FGFélix Gutiérrez
Félix Gutiérrez

1 September 2007 in Current HIV Research
Verified
Journal Article
Closed access
PDF file
SPSergio Padilla
Sergio Padilla
JGJuan A. Gallego
Juan A. Gallego
MMMar Masia
Mar Masia
FAFrancisco Ardoy
Francisco Ardoy
IHIldefonso Hernandez
Ildefonso Hernandez
FGFelix Gutierrez
Felix Gutierrez
To evaluate ultrasonography and anthropometry for the measurement of regional body fat in HIV infected patients. In a cross-sectional study, 61 patients receiving antiretroviral therapy underwent ultrasonography and anthropometry for measuring body fat at abdominal, peripheral and facial levels. Reproducibility and accuracy of the measurements at the different compartments were determined using quantitative computed tomography (CT) and clinical evaluation of lipodystrophy as reference standard. Intrabdominal and subcutaneous abdominal fat assessed by ultrasonography correlated with visceral and subcutaneous abdominal fat quantified by CT (r=0.74, P < 0.001, and r=0.84, P < 0.001, respectively). Ultrasound-determined subcutaneous fat at mid-thigh level correlated with adipose tissue area measured by CT (r = 0.84, P < 0.001). Waist-to-hip ratio (r=0.69, P < 0.001), suprailiac skinfold (r=0.78, P < 0.001) and mid-thigh skinfold thickness (r=0.83, P < 0.001) were also significantly correlated with visceral abdominal fat, subcutaneous abdominal fat, and with subcutaneous leg fat quantified by CT, respectively. Poorer correlations were found between ultrasonographic and anthropometric assessments of facial fat, and adipose tissue measured by CT (r=0.15, P=0.25, and r=0.58; P < 0.001; respectively). Reproducibility was higher for anthropometry than for ultrasonography in most body regions. The highest variability was observed for ultrasonographic assessment of facial fat (median inter-observer coefficient of variation, 32.10%). Using the clinical diagnosis of lipodystrophy as reference, the best accuracy was observed for ultrasounddetermined intrabdominal fat, waist-to-hip ratio and subcutaneous crural fat measured by ultrasonography. Ultrasonography and anthropometry are fairly accurate and reproducible methods for the evaluation of intrabdominal and peripheral fat. Its role for assessing facial fat seems to be more limited.

31 October 2006 in Journal of Clinical Virology
Verified
Journal Article
Closed access
FGFélix Gutiérrez
Félix Gutiérrez
MMMar Masiá
Mar Masiá
SPSergio Padilla
Sergio Padilla
Jose-Manuel Ramos-RinconJose-Manuel Ramos-Rincon
Jose-Manuel Ramos-Rincon
EBEnrique Bernal-Morell
Enrique Bernal-Morell
AMAlberto Martin-Hidalgo
Alberto Martin-Hidalgo